Free tool
Upcoming earnings calendar
See who reports in the next 30, 60 or 90 days, from the ~22,000 stocks we cover — filter by cap, sector, theme or market, then open any ticker for the full analysis.
See who reports in the next 30, 60 or 90 days, from the ~22,000 stocks we cover — filter by cap, sector, theme or market, then open any ticker for the full analysis.
See who reports in the US in the next 90 days, from the ~22,000 stocks we cover — filter by cap, sector, theme or market, then open any ticker for the full analysis.
41 companies reporting in the next 90 days. Clear filters
Data as of Aug 26, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Theme | Market cap (USD) | 1M return | |
|---|---|---|---|---|---|
| Monday, Sep 28 · in 32 days · 1 company | |||||
| LNAI | Lunai Bioworks Inc. | Oncology | $9.97M | −1.35% | |
| Thursday, Oct 8 · in 42 days · 1 company | |||||
| NRIX | Nurix Therapeutics, Inc. | Oncology | $2.73B | +15.02% | |
| Monday, Oct 19 · in 53 days · 1 company | |||||
| SMMT | Summit Therapeutics Inc. | Oncology | $10.66B | +1.95% | |
| Tuesday, Oct 27 · in 61 days · 5 companies | |||||
| INCY | Incyte Corporation | ||||
Price chart, technicals, money flow, fundamentals and an AI-written read — one page per stock. Looking for a name that isn't listed? Jump straight to it:
| $26.29B |
| +9.13% |
| 0J9P.L | Incyte Corporation | Oncology | $21.10B | +1.97% |
| EXEL | Exelixis, Inc. | Oncology | $14.05B | +1.63% |
| 0IJO.L | Exelixis, Inc. | Oncology | $14.05B | +3.33% |
| RCUS | Arcus Biosciences, Inc. | Oncology | $4.02B | +13.40% |
| Thursday, Oct 29 · in 63 days · 3 companies | |||||
| 6MK.DE | Merck & Co., Inc. | Oncology | $380.73B | +11.62% | |
| MRK | Merck & Co., Inc. | Oncology | $371.70B | +19.65% | |
| BMY | Bristol-Myers Squibb Company | Oncology | $138.74B | +8.57% | |
| Friday, Oct 30 · in 64 days · 1 company | |||||
| HOWL | Werewolf Therapeutics, Inc. | Oncology | $42.93M | +96.47% | |
| Monday, Nov 2 · in 67 days · 1 company | |||||
| NUVB | Nuvation Bio Inc. | Oncology | $2.49B | +6.61% | |
| Tuesday, Nov 3 · in 68 days · 4 companies | |||||
| COGT | Cogent Biosciences, Inc. | Oncology | $6.39B | −9.00% | |
| 0J4V.L | Heron Therapeutics, Inc. | Oncology | $82.85M | +1.38% | |
| HRTX | Heron Therapeutics, Inc. | Oncology | $61.34M | −29.76% | |
| KPTI | Karyopharm Therapeutics Inc. Common Stock | Oncology | $42.19M | −72.92% | |
| Wednesday, Nov 4 · in 69 days · 3 companies | |||||
| RVMD | Revolution Medicines, Inc. | Oncology | $45.35B | +12.39% | |
| TNGX | Tango Therapeutics, Inc. | Oncology | $4.13B | −8.27% | |
| XNCR | Xencor, Inc. Common Stock | Oncology | $2.18B | +47.53% | |
| Thursday, Nov 5 · in 70 days · 8 companies | |||||
| LNTH | Lantheus Holdings, Inc. | Oncology | $6.58B | −6.63% | |
| RLAY | Relay Therapeutics, Inc. | Oncology | $4.51B | +10.35% | |
| IMNM | Immunome, Inc. | Oncology | $3.34B | +30.14% | |
| URGN | UroGen Pharma Ltd. | Oncology | $2.27B | +11.82% | |
| PLRX | Pliant Therapeutics, Inc. | Oncology | $73.69M | +5.56% | |
| TPST | Tempest Therapeutics, Inc. | Oncology | $18.36M | +18.72% | |
| LSTA | Lisata Therapeutics, Inc. | Oncology | $15.68M | +20.83% | |
| CRIS | Curis, Inc. | Oncology | $3.86M | −66.10% | |
| Monday, Nov 9 · in 74 days · 1 company | |||||
| KYNB | Kyntra Bio, Inc. | Oncology | $32.80M | +14.89% | |
| Wednesday, Nov 11 · in 76 days · 5 companies | |||||
| ERAS | Erasca, Inc. | Oncology | $6.16B | −5.88% | |
| CELC | Celcuity Inc. | Oncology | $4.44B | +12.16% | |
| SLS | SELLAS Life Sciences Group, Inc. | Oncology | $2.89B | +29.98% | |
| LTRN | Lantern Pharma Inc. | Oncology | $27.87M | −21.86% | |
| BFRI | Biofrontera Inc. | Oncology | $22.43M | +43.81% | |
| Thursday, Nov 12 · in 77 days · 5 companies | |||||
| CRDF | Cardiff Oncology, Inc. | Oncology | $79.35M | +21.43% | |
| BYSI | BeyondSpring Inc. | Oncology | $29.61M | −38.44% | |
| CLRB | Cellectar Biosciences, Inc. | Oncology | $24.01M | +4.96% | |
| PDSB | PDS Biotechnology Corporation | Oncology | $12.40M | −68.04% | |
| BCAB | BioAtla, Inc. | Oncology | $5.43M | −4.12% | |
| Monday, Nov 16 · in 81 days · 2 companies | |||||
| OSTX | OS Therapies Incorporated | Oncology | $76.68M | +7.84% | |
| PMVP | PMV Pharmaceuticals, Inc. | Oncology | $69.76M | +10.59% | |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India). Reporting dates are public estimates and can shift.